Flowr logo

FLWR - Flowr News Story

C$0.24 -0.0  -2.0%

Last Trade - 13/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £47.8m
Enterprise Value £79.2m
Revenue £4.41m
Position in Universe 944th / 2704

The Flowr Corporation Announces Fourth Quarter 2020 Earnings Date

Sat 10th April, 2021 12:30am
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210409:nGNX8QCWcm&default-theme=true

* Flowr will release fourth quarter earnings after market close on Wednesday,
April 28, 2021 and will host a conference call to review results on Wednesday,
April 28, 2021 at 5:30 p.m. (Eastern Time).
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V:
FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces that the
Company will release its fourth quarter and full year 2020 results after the
close of the financial markets on Wednesday, April 28, 2021. There will be a
conference call and webcast to review these results on Wednesday, April 28 at
5:30 p.m. (Eastern Time).

Conference call and webcast details are as follows:

Webcast: flowrcorp.com/investors
Online registration: http://www.directeventreg.com/registration/event/8493169

Conference call replay details are as follows:

Toll Free: 1-800-585-8367
Toll/International: 1-416-621-4642
Passcode: 8493169
Webcast: flowrcorp.com/investors
The replay of the conference call will be available through midnight on
Friday, May 7, 2021.

Terrace Acquisition – Issuance of Shares

In addition, in connection with the Company’s acquisition (the
“Acquisition”) of Terrace Global Inc. (“Terrace”), the Company has
completed its previously announced settlement in respect of the change of
control payments owed to certain former directors and officers of Terrace (the
“Change of Control Payment”) and the fees owed to Terrace’s financial
advisor, Hyperion Capital Inc. (“Hyperion”), in respect of the Acquisition
(the “Hyperion Payment”). An aggregate of 276,569 Common Shares were
issued at a deemed price of $0.44 per Common Share pursuant to the Change of
Control Payment. An aggregate of 467,681 Common Shares were issued at a deemed
price of $0.385 per Common Share pursuant to the Hyperion Payment.

Private Placement

The Company announced today the termination of the previously announced
non-brokered private placement of common shares of Flowr for gross proceeds of
up to $1,000,000.

About The Flowr Corporation

The Flowr Corporation is a Toronto-headquartered cannabis company with
operations in Canada, Europe, and Australia. Its Canadian operating campus,
located in Kelowna, BC, includes a purpose-built, GMP-designed indoor
cultivation facility; an outdoor and greenhouse cultivation site; and a
state-of-the-art R&D facility. From this campus, Flowr produces recreational
and medicinal products. Internationally, Flowr intends to service the global
medical cannabis market through its subsidiary Holigen, which has a license
for cannabis cultivation in Portugal and operates GMP licensed facilities in
both Portugal and Australia.

Flowr aims to support improving outcomes through responsible cannabis use and,
as an established expert in cannabis cultivation, strives to be the brand of
choice for consumers and patients seeking the highest-quality craftsmanship
and product consistency across a portfolio of differentiated cannabis
products.

For more information, please visit flowrcorp.com
(https://www.globenewswire.com/Tracker?data=kLO_L1XWVwXautRIoicDMtUqhieGsGsc0noS6YhY5B6TSHVTaAPePbL_DIclWVE7ORpKA7PQQ_Ryxn8meRGwUQ==)
or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation.

On behalf of The Flowr Corporation:
Irina Hossu
Chief Financial Officer

CONTACT INFORMATION:

INVESTORS & MEDIA:
Irina Hossu, Chief Financial Officer
Irina.hossu@flowr.ca

(https://www.globenewswire.com/NewsRoom/AttachmentNg/c2f80cdc-4dec-49f4-96f1-9dc064de4a51)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.